Novanta Inc (NOVT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Novanta Inc (NOVT) has a cash flow conversion efficiency ratio of 0.038x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($50.31 Million) by net assets ($1.31 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Novanta Inc for the company's overall valuation and market capitalisation.
Novanta Inc - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Novanta Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Novanta Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Novanta Inc ranked by their cash flow conversion efficiency. Explore Novanta Inc (NOVT) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FORM.DE C.Y C.ADR 1/5/EO1
F:FCC0
|
N/A |
|
Vietnam Dairy Products JSC
VN:VNM
|
0.050x |
|
Bechtle AG
XETRA:BC8
|
-0.057x |
|
RTL Group SA
F:RRTL
|
-0.003x |
|
Reynolds Consumer Products Inc
NASDAQ:REYN
|
0.044x |
|
Xi an Bright Laser Tech Co Ltd
SHG:688333
|
0.022x |
|
Spire Inc
NYSE:SR
|
13076.512x |
|
Fortune Brands Innovations Inc.
NYSE:FBIN
|
0.036x |
Annual Cash Flow Conversion Efficiency for Novanta Inc (1998–2025)
The table below shows the annual cash flow conversion efficiency of Novanta Inc from 1998 to 2025. View NOVT stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.31 Billion | $64.06 Million | 0.049x | -77.07% |
| 2024-12-31 | $745.70 Million | $158.51 Million | 0.213x | +19.22% |
| 2023-12-31 | $673.46 Million | $120.08 Million | 0.178x | +13.44% |
| 2022-12-31 | $577.59 Million | $90.78 Million | 0.157x | -13.41% |
| 2021-12-31 | $521.29 Million | $94.62 Million | 0.182x | -38.28% |
| 2020-12-31 | $476.81 Million | $140.24 Million | 0.294x | +94.00% |
| 2019-12-31 | $417.17 Million | $63.25 Million | 0.152x | -37.72% |
| 2018-12-31 | $368.25 Million | $89.65 Million | 0.243x | +37.69% |
| 2017-12-31 | $358.47 Million | $63.38 Million | 0.177x | -4.23% |
| 2016-12-31 | $258.87 Million | $47.79 Million | 0.185x | +35.18% |
| 2015-12-31 | $244.70 Million | $33.42 Million | 0.137x | -31.78% |
| 2014-12-31 | $211.25 Million | $42.29 Million | 0.200x | -1.37% |
| 2013-12-31 | $242.40 Million | $49.20 Million | 0.203x | +62.92% |
| 2012-12-31 | $228.21 Million | $28.43 Million | 0.125x | -42.26% |
| 2011-12-31 | $209.36 Million | $45.17 Million | 0.216x | +469.40% |
| 2010-12-31 | $81.12 Million | $-4.74 Million | -0.058x | -122.96% |
| 2009-12-31 | $152.90 Million | $38.90 Million | 0.254x | 0.00% |
| 2008-12-31 | $152.90 Million | $38.90 Million | 0.254x | +88.84% |
| 2007-12-31 | $278.24 Million | $37.49 Million | 0.135x | +31.11% |
| 2006-12-31 | $343.07 Million | $35.26 Million | 0.103x | +547.68% |
| 2005-12-31 | $306.56 Million | $4.86 Million | 0.016x | -86.30% |
| 2004-12-31 | $305.56 Million | $35.40 Million | 0.116x | +38.41% |
| 2003-12-31 | $260.79 Million | $21.83 Million | 0.084x | +81.78% |
| 2002-12-31 | $254.48 Million | $11.72 Million | 0.046x | +174.37% |
| 2001-12-31 | $282.33 Million | $-17.48 Million | -0.062x | -75.22% |
| 2000-12-31 | $289.27 Million | $-10.22 Million | -0.035x | -37.87% |
| 1999-12-31 | $171.70 Million | $-4.40 Million | -0.026x | +55.74% |
| 1998-12-31 | $120.90 Million | $-7.00 Million | -0.058x | -- |
About Novanta Inc
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets la… Read more